139 related articles for article (PubMed ID: 11592062)
21. Vascular adhesion protein-1, intercellular adhesion molecule-1 and P-selectin mediate leukocyte binding to ischemic heart in humans.
Jaakkola K; Jalkanen S; Kaunismäki K; Vänttinen E; Saukko P; Alanen K; Kallajoki M; Voipio-Pulkki LM; Salmi M
J Am Coll Cardiol; 2000 Jul; 36(1):122-9. PubMed ID: 10898423
[TBL] [Abstract][Full Text] [Related]
22. Function-blocking antibodies to human vascular adhesion protein-1: a potential anti-inflammatory therapy.
Kirton CM; Laukkanen ML; Nieminen A; Merinen M; Stolen CM; Armour K; Smith DJ; Salmi M; Jalkanen S; Clark MR
Eur J Immunol; 2005 Nov; 35(11):3119-30. PubMed ID: 16224816
[TBL] [Abstract][Full Text] [Related]
23. Vascular adhesion protein 1 (VAP-1) functions as a molecular brake during granulocyte rolling and mediates recruitment in vivo.
Tohka S; Laukkanen M; Jalkanen S; Salmi M
FASEB J; 2001 Feb; 15(2):373-82. PubMed ID: 11156953
[TBL] [Abstract][Full Text] [Related]
24. Lymphocyte-vascular adhesion protein-2 is a novel 70-kDa molecule involved in lymphocyte adhesion to vascular endothelium.
Airas L; Salmi M; Jalkanen S
J Immunol; 1993 Oct; 151(8):4228-38. PubMed ID: 8409398
[TBL] [Abstract][Full Text] [Related]
25. Enzymatic control of leukocyte trafficking: role of VAP-1.
Salmi M; Jalkane S
Adv Exp Med Biol; 2002; 512():57-63. PubMed ID: 12405188
[No Abstract] [Full Text] [Related]
26. Developmental regulation of the adhesive and enzymatic activity of vascular adhesion protein-1 (VAP-1) in humans.
Salmi M; Jalkanen S
Blood; 2006 Sep; 108(5):1555-61. PubMed ID: 16556889
[TBL] [Abstract][Full Text] [Related]
27. Involvement of SSAO/VAP-1 in oxygen-glucose deprivation-mediated damage using the endothelial hSSAO/VAP-1-expressing cells as experimental model of cerebral ischemia.
Sun P; Solé M; Unzeta M
Cerebrovasc Dis; 2014; 37(3):171-80. PubMed ID: 24503888
[TBL] [Abstract][Full Text] [Related]
28. A novel endothelial cell molecule mediating lymphocyte binding in humans.
Jalkanen S; Salmi M
Behring Inst Mitt; 1993 Aug; (92):36-43. PubMed ID: 8250815
[TBL] [Abstract][Full Text] [Related]
29. Role of adhesion molecules in chronic allograft rejection.
Nowaczyk M; Górski A; Durlik M; Wyzgał J; Perkowska-Francka A
Arch Immunol Ther Exp (Warsz); 1999; 47(6):373-5. PubMed ID: 10608294
[TBL] [Abstract][Full Text] [Related]
30. Lymphocyte traffic through sinusoidal endothelial cells is regulated by hepatocytes.
Edwards S; Lalor PF; Nash GB; Rainger GE; Adams DH
Hepatology; 2005 Mar; 41(3):451-9. PubMed ID: 15723297
[TBL] [Abstract][Full Text] [Related]
31. Vascular adhesion protein 1 mediates binding of T cells to human hepatic endothelium.
McNab G; Reeves JL; Salmi M; Hubscher S; Jalkanen S; Adams DH
Gastroenterology; 1996 Feb; 110(2):522-8. PubMed ID: 8566600
[TBL] [Abstract][Full Text] [Related]
32. VAP-1, a novel molecule linked to endothelial damage and kidney function in kidney allograft recipients.
Koc-Zorawska E; Malyszko J; Malyszko JS; Mysliwiec M
Kidney Blood Press Res; 2012; 36(1):242-7. PubMed ID: 23154672
[TBL] [Abstract][Full Text] [Related]
33. Vascular adhesion protein-1 is actively involved in the development of inflammatory lesions in rat models of multiple sclerosis.
Elo P; Tadayon S; Liljenbäck H; Teuho J; Käkelä M; Koskensalo K; Saunavaara V; Virta J; Veres TZ; Kiviniemi A; Saraste A; Marjamäki P; Airas L; Jalkanen S; Roivainen A
J Neuroinflammation; 2018 May; 15(1):128. PubMed ID: 29716612
[TBL] [Abstract][Full Text] [Related]
34. Distribution of cell adhesion molecules (ICAM-1, VCAM-1, ELAM-1) in renal tissue during allograft rejection.
Brockmeyer C; Ulbrecht M; Schendel DJ; Weiss EH; Hillebrand G; Burkhardt K; Land W; Gokel MJ; Riethmüller G; Feucht HE
Transplantation; 1993 Mar; 55(3):610-5. PubMed ID: 7681228
[TBL] [Abstract][Full Text] [Related]
35. Expression of vascular cell adhesion molecule-1 in kidney allograft rejection.
Alpers CE; Hudkins KL; Davis CL; Marsh CL; Riches W; McCarty JM; Benjamin CD; Carlos TM; Harlan JM; Lobb R
Kidney Int; 1993 Oct; 44(4):805-16. PubMed ID: 7505038
[TBL] [Abstract][Full Text] [Related]
36. Carbohydrates located on the top of the "cap" contribute to the adhesive and enzymatic functions of vascular adhesion protein-1.
Maula SM; Salminen T; Kaitaniemi S; Nymalm Y; Smith DJ; Jalkanen S
Eur J Immunol; 2005 Sep; 35(9):2718-27. PubMed ID: 16082728
[TBL] [Abstract][Full Text] [Related]
37. Vascular adhesion protein-1 as a potential therapeutic target in liver disease.
Lalor PF; Tuncer C; Weston C; Martin-Santos A; Smith DJ; Adams DH
Ann N Y Acad Sci; 2007 Sep; 1110():485-96. PubMed ID: 17911464
[TBL] [Abstract][Full Text] [Related]
38. Distinct expression of cell-cell and cell-matrix adhesion molecules on endothelial cells in human heart and lung transplants.
Steinhoff G; Behrend M; Richter N; Schlitt HJ; Cremer J; Haverich A
J Heart Lung Transplant; 1995; 14(6 Pt 1):1145-55. PubMed ID: 8719462
[TBL] [Abstract][Full Text] [Related]
39. Vascular adhesion protein-1 is involved in both acute and chronic inflammation in the mouse.
Merinen M; Irjala H; Salmi M; Jaakkola I; Hänninen A; Jalkanen S
Am J Pathol; 2005 Mar; 166(3):793-800. PubMed ID: 15743791
[TBL] [Abstract][Full Text] [Related]
40. In vivo detection of vascular adhesion protein-1 in experimental inflammation.
Jaakkola K; Nikula T; Holopainen R; Vähäsilta T; Matikainen MT; Laukkanen ML; Huupponen R; Halkola L; Nieminen L; Hiltunen J; Parviainen S; Clark MR; Knuuti J; Savunen T; Kääpä P; Voipio-Pulkki LM; Jalkanen S
Am J Pathol; 2000 Aug; 157(2):463-71. PubMed ID: 10934150
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
